Work

Enabling Pharmacogenomic Clinical Trials Through Sampling

Year: 2010

Type: article

Source: Pharmacogenomics

DOI: 10.2217/pgs.10.139

Authors: Amelia Warner, Anita Nelsen, Anahita Bhathena, Kevin FitzGerald, Sandra Gilardi, Ellen Kelso, Bartha Knoppers, Howard L McLeod, Robert Nelson, Yoshi Uyama, Jennifer Weisman, Allen Rudman

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Abbott (United States), Georgetown University, Bristol-Myers Squibb (United States), McGill University, University of North Carolina at Chapel Hill, United States Food and Drug Administration, Pharmaceuticals and Medical Devices Agency

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2056338881

FWCI: 0.968

Cites: 5

Cited by: 3

Related to: 10